- Posted August 01, 2014
- Tweet This | Share on Facebook
State inmates may get costly hepatitis C drug
LANSING (AP) - A new hepatitis C treatment that costs $1,000 pill is expected to be available to Michigan inmates.
The Detroit News reports the Michigan Department of Corrections 2015 budget, which takes effect Oct. 1, includes $4.4 million for the drug, which holds promise for a cure for the liver-damaging disease.
Corrections spokesman Russ Marlan says pills will be "targeted to the serious cases where the traditional hepatitis C drugs have been ineffective."
Meanwhile, Michigan Department of Community Health spokeswoman Angela Minicuci says the drug is being provided on a "case by case" basis to non-inmate Medicaid patients.
Illinois and other states are restricting Sovaldi's use, according to a July 23 earnings call held by the drug's maker, California-based Gilead Sciences Inc. The Food and Drug Administration approved Sovaldi in December.
Published: Fri, Aug 01, 2014
headlines Oakland County
headlines National
- New Legalese: You may have heard a deepfake, but what about ‘Twiqbal’?
- From Intake to Outcome: An in-house lawyer’s guide to matter management solutions
- 2 BigLaw firms in merger talks that could produce 1,600-lawyer firm with top 50 revenue
- Send in the paralegals
- Lawyer reprimanded after mistakenly emailing opposing counsel with plan to avoid judge’s call
- ‘I don’t play well’ judge who threatened to track down, jail misbehaving litigant gets tossed from case